Literature DB >> 21503679

Helicobacter bilis colonization enhances susceptibility to Typhlocolitis following an inflammatory trigger.

Zhiping Liu1, Amanda E Ramer-Tait, Abigail L Henderson, Cumhur Yusuf Demirkale, Dan Nettleton, Chong Wang, Jesse M Hostetter, Albert E Jergens, Michael J Wannemuehler.   

Abstract

BACKGROUND: Aberrant mucosal immune responses to antigens of the resident microbiota are a significant cause of inflammatory bowel diseases (IBD), as are genetic and environmental factors. Previous work from our laboratory demonstrated that Helicobacter bilis colonization of immunocompetent, defined microbiota mice induced antigen-specific immune responses to the resident microbiota, yet these mice failed to develop colitis, suggesting that the immunological provocation induced by H. bilis alone was insufficient to induce disease. AIM: The purpose of this study was to test the hypothesis that the introduction of a bacterial provocateur such as H. bilis enhances the host's susceptibility to IBD following an inflammatory event.
METHODS: Defined microbiota (DM) mice colonized with H. bilis were administered low dose (1.5%) dextran sodium sulfate (DSS) in drinking water for 5 days followed by a 4-day restitution period. Severity of lesions was assessed grossly and microscopically. Differential expression of select mucosal genes and histopathologic lesions was characterized.
RESULTS: Helicobacter bilis colonization increased the severity of intestinal inflammation induced by an inflammatory trigger in the form of low-dose DSS. An analysis of the molecular and cellular mechanisms associated with H. bilis colonization revealed significant increases in expression of mucosal genes associated with lymphocyte activation and inflammatory cell chemotaxis as well as increased infiltration of mucosal macrophages and T cells in mice colonized with H. bilis prior to DSS treatment versus DSS treatment alone.
CONCLUSIONS: These results indicate that prior colonization with H. bilis heightens the host's sensitivity to enteric inflammation by altering mucosal homeostasis and initiating immune cell activation and migration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21503679     DOI: 10.1007/s10620-011-1701-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  46 in total

1.  Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production.

Authors:  A J da Silva; Z Li; C de Vera; E Canto; P Findell; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Suppression of experimental colitis by intestinal mononuclear phagocytes.

Authors:  Joseph E Qualls; Alan M Kaplan; Nico van Rooijen; Donald A Cohen
Journal:  J Leukoc Biol       Date:  2006-08-03       Impact factor: 4.962

3.  A prospective study of first attacks of inflammatory bowel disease and non-relapsing colitis. Microbiologic findings.

Authors:  G Schumacher; B Kollberg; B Sandstedt; C Jorup; L Grillner; A Ljungh; R Möllby
Journal:  Scand J Gastroenterol       Date:  1993-12       Impact factor: 2.423

4.  Induction of differential immune reactivity to members of the flora of gnotobiotic mice following colonization with Helicobacter bilis or Brachyspira hyodysenteriae.

Authors:  Albert E Jergens; Andrea Dorn; Jenny Wilson; Krystal Dingbaum; Abigail Henderson; Zhiping Liu; Jesse Hostetter; Richard B Evans; Michael J Wannemuehler
Journal:  Microbes Infect       Date:  2006-04-18       Impact factor: 2.700

5.  Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Authors:  A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

6.  Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.

Authors:  Seung G Kang; Ronald J Piniecki; Harm Hogenesch; Hyung W Lim; Eric Wiebke; Stephen E Braun; Satoshi Matsumoto; Chang H Kim
Journal:  Gastroenterology       Date:  2007-01-05       Impact factor: 22.682

7.  Inducible nitric oxide synthase immunoreactivity in the granulomatous intestinal lesions of naturally occurring bovine Johne's disease.

Authors:  J Hostetter; E Huffman; K Byl; E Steadham
Journal:  Vet Pathol       Date:  2005-05       Impact factor: 2.221

8.  Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.

Authors:  M A Musci; L R Hendricks-Taylor; D G Motto; M Paskind; J Kamens; C W Turck; G A Koretzky
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

Review 9.  The genetics of Crohn's disease.

Authors:  Johan Van Limbergen; David C Wilson; Jack Satsangi
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

10.  Infectious gastroenteritis and risk of developing inflammatory bowel disease.

Authors:  Chad K Porter; David R Tribble; Pablo A Aliaga; Heather A Halvorson; Mark S Riddle
Journal:  Gastroenterology       Date:  2008-06-05       Impact factor: 22.682

View more
  17 in total

Review 1.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 2.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

3.  Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease.

Authors:  Sureshkumar Muthupalani; Zhongming Ge; Yan Feng; Barry Rickman; Melissa Mobley; Amanda McCabe; Nico Van Rooijen; James G Fox
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

Review 4.  Microbiota and reproducibility of rodent models.

Authors:  Craig L Franklin; Aaron C Ericsson
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

5.  Constitutive androstane receptor regulates the intestinal mucosal response to injury.

Authors:  Grace M Hudson; Kyle L Flannigan; Sarah L Erickson; Fernando A Vicentini; Alexandra Zamponi; Christina L Hirota; Laurie Alston; Christophe Altier; Subrata Ghosh; Kevin P Rioux; Sridhar Mani; Thomas K Chang; Simon A Hirota
Journal:  Br J Pharmacol       Date:  2017-04-19       Impact factor: 8.739

6.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

7.  A real-time PCR assay for accurate quantification of the individual members of the Altered Schaedler Flora microbiota in gnotobiotic mice.

Authors:  João Carlos Gomes-Neto; Sara Mantz; Kyler Held; Rohita Sinha; Rafael R Segura Munoz; Robert Schmaltz; Andrew K Benson; Jens Walter; Amanda E Ramer-Tait
Journal:  J Microbiol Methods       Date:  2017-02-09       Impact factor: 2.363

Review 8.  Manipulating the Gut Microbiota: Methods and Challenges.

Authors:  Aaron C Ericsson; Craig L Franklin
Journal:  ILAR J       Date:  2015

Review 9.  The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community.

Authors:  Meghan Wymore Brand; Michael J Wannemuehler; Gregory J Phillips; Alexandra Proctor; Anne-Marie Overstreet; Albert E Jergens; Roger P Orcutt; James G Fox
Journal:  ILAR J       Date:  2015

10.  Giardia Infection of the Small Intestine Induces Chronic Colitis in Genetically Susceptible Hosts.

Authors:  Sara M Dann; Christine H Y Le; Elaine M Hanson; Matthew C Ross; Lars Eckmann
Journal:  J Immunol       Date:  2018-06-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.